What is he best known for?
The fields of study he is best known for:
His primary areas of investigation include Cancer research, Genetics, microRNA, Breast cancer and Gene.
The various areas that Joel S. Parker examines in his Cancer research study include DNA methylation, Immunology, KRAS, Carcinoma and ARID1A.
Joel S. Parker focuses mostly in the field of Genetics, narrowing it down to matters related to Computational biology and, in some cases, DNA microarray, Gene silencing and Genome.
His work in microRNA addresses issues such as PBRM1, which are connected to fields such as GNAS complex locus, Pancreatic cancer, Proteomic Profiling, Chromatin and Signal transduction.
His work in the fields of Claudin-Low overlaps with other areas such as Invasive Lobular Breast Carcinoma.
The Internal medicine study combines topics in areas such as Oncology and Pathology.
His most cited work include:
- Comprehensive molecular portraits of human breast tumours (7253 citations)
- Repeated observation of breast tumor subtypes in independent gene expression data sets (4338 citations)
- The cancer genome atlas pan-cancer analysis project (3506 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Cancer research, Internal medicine, Oncology, Breast cancer and Cancer.
As a part of the same scientific study, Joel S. Parker usually deals with the Cancer research, concentrating on Carcinoma and frequently concerns with Head and neck squamous-cell carcinoma.
Joel S. Parker studied Internal medicine and Pathology that intersect with Phenotype.
The study incorporates disciplines such as Exome sequencing, Colorectal cancer, Clinical trial and Proportional hazards model in addition to Oncology.
His Breast cancer research integrates issues from Metastasis and Gene expression profiling.
As a part of the same scientific family, Joel S. Parker mostly works in the field of Cancer, focusing on Gene and, on occasion, Computational biology.
He most often published in these fields:
- Cancer research (31.07%)
- Internal medicine (30.23%)
- Oncology (26.84%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (30.23%)
- Oncology (26.84%)
- Cancer research (31.07%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Internal medicine, Oncology, Cancer research, Breast cancer and Cancer.
His research in Oncology intersects with topics in Exome sequencing, Clinical trial, FOLFIRI, Proportional hazards model and Colorectal cancer.
His Cancer research research is multidisciplinary, relying on both Carcinogenesis, Immune system, Immunotherapy and Mutation.
His Breast cancer research is multidisciplinary, incorporating perspectives in Transcriptome, Metastasis and Gene.
His Gene research entails a greater understanding of Genetics.
His research links Pik3ca mutation with Cancer.
Between 2018 and 2021, his most popular works were:
- Pan-cancer analysis of whole genomes (538 citations)
- Cells exhibiting strong p16INK4a promoter activation in vivo display features of senescence (68 citations)
- B Cells and T Follicular Helper Cells Mediate Response to Checkpoint Inhibitors in High Mutation Burden Mouse Models of Breast Cancer. (58 citations)
In his most recent research, the most cited papers focused on:
Joel S. Parker focuses on Cancer research, Breast cancer, Internal medicine, Computational biology and Oncology.
He combines subjects such as Tumor microenvironment, Mammary tumor and Immunotherapy with his study of Cancer research.
Breast cancer is the subject of his research, which falls under Cancer.
His Internal medicine research incorporates themes from Classifier and Epigenetics.
Joel S. Parker interconnects RNA, Genome, DNA, Cytotoxic T cell and Major histocompatibility complex in the investigation of issues within Computational biology.
His work deals with themes such as Nurses' Health Study, Prospective cohort study, Clinical trial, Methylation and Disease, which intersect with Oncology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
